Reckitt Benckiser Plc to Buy Paras Pharmaceuticals Ltd. for $726M

Published: Dec 13, 2010

PE Hub -- Reckitt Benckiser will pay 32.6 billion rupees ($726 million) for private equity-backed Paras Pharmaceuticals, Reuters reported. Buyout shop Actis owns 63% of India’s Paras. Other shareholders include Silicon Valley-based venture firm Sequoia Capital. UK-based Reckitt Benckiser produces a wide range of household, health and personal care products. Actis has $4.7 billion under management.

Back to news